When: 50 SMA reclaim at $147.12

Then: Enter 1% starter position

When: Operating margin stabilizes above 19-20% for one quarter after 50 SMA reclaim

Then: Scale to full 2-3% position

When: Close below $137.62 on volume >7M

Then: Exit entire position; mandatory reassessment

HOLD

• Operating margin declined sequentially every quarter from Q3 FY25 to Q2 FY26 with no stabilization; current 18.6 percent may not be the floor
• Gross margin compressed from 51.4 to 48.5; SG&A expanded by 430 million dollars in a single quarter
• Revenue plateau at 21.2 billion dollars for two consecutive quarters; Q2 EPS down 15 percent year over year
• Stock trading below all three moving averages and lost 13 percent from February peak despite dividend rotation
• 10-year Treasury at 4.5 percent neutralizes the 3 percent dividend yield argument; 21.6x trailing earnings shows market distrusts forward EPS estimates of 7.40 dollars
• Thorne acquisition at 3.8 billion dollars (~29 percent of trailing free cash flow) is poorly timed given margin collapse and flat revenue
• Technical indicators show no bullish divergence: MACD at negative 0.86, histogram at negative 0.32, no RSI divergence
• Lower Bollinger band tag at 142.34 in confirmed downtrend is a continuation signal, not exhaustion; volume contraction suggests no bid, not exhausted sellers
• Sentiment data carries LOW confidence rating; 12 buy features in dividend press outlets are content marketing, not institutional flow
• Tightened add conditions required: sequential margin stabilization for two quarters, gross margin above 50 percent, and hard stop at 141.50 (not 142)

→ vs aggressive: Margin recovery thesis unsupported by data: no sequential quarter of stabilization, no management guidance on recovery timeline, and Q2 EPS down 15 percent year over year

→ vs aggressive: Rotation narrative fails for PG specifically: stock below all moving averages, down 13 percent from February peak, underperforming defensive cohort despite sector tailwind

→ vs aggressive: PEG normalization uses unreliable forward EPS: market pricing 21.6x trailing earnings demonstrates it does not trust the 7.40 dollars forward estimate; cannot claim market is wrong on price while trusting it on rotation

→ vs aggressive: Thorne acquisition at 3.8 billion dollars during margin collapse and flat revenue is speculative, not strategic; no synergy numbers, no accretion math, no integration timeline provided

→ vs aggressive: Technical analysis misreads lower band tag: in confirmed downtrend these are continuation signals; volume contraction means no bid, not exhausted sellers; MACD histogram not decelerating

HOLD

• Operating margin has fallen sequentially for five straight quarters with no deceleration—trend not trough
• DCF intrinsic value range is $145-$160 (narrower than Aggressive's $160-$170) given zero confirmation of margin recovery
• Aggressive Analyst conflates intrinsic value calculation with price target; FCF assumptions unconfirmed
• PG is underperforming within its defensive cohort despite rotation into defensives—company-specific concerns dominate
• Conservative Analyst's two-quarter margin stabilization requirement essentially gives up the $130-$135 move before arriving
• Bounce entry should scale in two tranches: half-size on lower band tag with volume contraction, second half on reclaim of 10 EMA at $144.69 with above-average volume
• One quarter of sequential operating margin improvement above 19-20% is sufficient trigger for accumulation at $135 (not full recovery to 26%)
• 50 SMA reclaim at $147.12 warrants 1% starter position but cap full conviction add at 2-3% until margin confirmation
• Thorne acquisition adds 1-2% to terminal value—modest positive, not a catalyst for aggressive adds
• Forward PEG normalization is intellectually clever but operationally dangerous; market paying 21.6x trailing because it doesn't believe forward estimates
• 3% dividend yield plus option value of defensive allocation remains meaningful but insufficient to justify aggressive adds at $143
• KMB-Kenvue competitive threat is medium-term risk to personal care share, factors into terminal value not near-term

→ vs aggressive: Treating DCF intrinsic value like a price target; assuming margin recovery that hasn't shown in any data point; overstating rotation working for PG specifically when stock is below all three moving averages

→ vs conservative: Demanding two quarters of margin stabilization before adding in $130-$135 zone is too restrictive; triple confirmation requirement on bounce (daily close above lower band plus reversal candle plus follow-through) will cause buying $2 higher; framing absence of retail flow as bearish is too negative